New data shows Abbott’s FreeStyle Libre 3 system is most accurate 14-day continuous glucose monitor
June 7, 2022 – Abbott announced late-breaking clinical data that demonstrate the FreeStyle Libre® 3 system has an overall mean absolute relative difference (MARD) of 7.9%,1 making it the…